IHC revealed that 17/25 GCs contained PD-L1+ stromal cells (range 5-75% positive cells) with no significant difference between EBV+/- specimens; however, only 3/25 specimens contained PD-L1+ tumor cells (all EBV+). The gene discussed is CD274; the disease is neoplasm.